Frost & Sullivan: Mercanis Receives the 2025 European Agentic AI Product Leadership Recognition for its Excellence in Intelligent Procurement Transformation
Frost & Sullivan recognizes Mercanis for product innovation, customer-centricity, and AI leadership in redefining digital procurement across Europe. SAN ANTONIO, Jan. 26, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that...
Accevo Receives Frost & Sullivan's 2025 European Enabling Technology Leadership Recognition for Manufacturing Software in Smart Factories
The company is acknowledged for enabling digital transformation, performance-driven smart manufacturing, and scalable manufacturing software innovation across European factories and globally. SAN ANTONIO, Jan. 26, 2026 /PRNewswire/ -- Frost &...
CNEY Receives Nasdaq Delisting Determination for Minimum Bid Price Deficiency
LISHUI, China, Jan. 24, 2026 /PRNewswire/ -- CN Energy Group. Inc. (NASDAQ: CNEY) ("CNEY" or the "Company"), a Nasdaq-listed company, today announced that it received a written notice from the Listing Qualifications Staff of The Nasdaq Stock Market...
Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor
Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) paves the way for ISM8969 clinical study in the United States. The Phase I clinical trial aims to evaluate safety, tolerability, and pharmacokinetics profiles....
D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two...
WuXi AppTec Receives Double "A" Rating from CDP for Climate Change and Water Security Leadership
SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced that it has been recognized on the "A List" for leadership in corporate...
Aeronero Receives Frost & Sullivan's 2025 Global Transformational Innovation Leadership Recognition for Pioneering Advancements in Atmospheric Water Generation
Recognized for redefining water security through breakthrough hybrid atmospheric water generation technology and sustainable innovation SAN ANTONIO, Jan. 13, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Aeronero has been...
Frost & Sullivan: Paragraf Receives the 2025 European Graphene-Based Electronics Manufacturing Technology Innovation Leadership Recognition for Excellence in Semiconductor Innovation
The company's direct, contaminant-free graphene deposition method is a manufacturing breakthrough SAN ANTONIO, Jan. 7, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Paragraf has earned the 2025 European Technology Innovation...
BlueSG Receives Frost & Sullivan's 2025 Asia-Pacific Customer Value Leadership Recognition for Excellence in Car-sharing Industry
Frost & Sullivan applauds BlueSG's customer-centric approach, digital transformation, and operational agility in redefining urban mobility through its innovative car-sharing model. SAN ANTONIO, Jan. 6, 2026 /PRNewswire/ -- Frost & Sullivan...
Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that its Investigational New Drug (IND) application for SKB105 (also known as CR-003), an internally...